Transcription of 2020 Annual Report
{{id}} {{{paragraph}}}
Example: barber
2020 Annual Report
2020 Annual ReportOur MissionTo discover, develop and deliver innovative medicines that help patients prevail over serious diseasesOur VisionTo be the world's leading biopharma company that transforms patients' lives through scienceOur ValuesIntegrity | Innovation | Urgency | Passion | Accountability | InclusionCover image: During a year when most of us were separated by the pandemic, our global collective efforts ensured that individual contributions came together to make a significant impact for Full-Year RevenuesGAAP Full-Year Change vs. Prior Year*63%Worldwide Revenues$ Forma Full-Year Change vs. Prior Year**7% We created a leading biopharma company that combines the agility of a biotech company with the reach and resources of an established pharmaceutical corporation.
and Zeposia (ozanimod). We added five new indications to our immuno-oncology portfolio, including four for our dual immunotherapy treatment, Opdivo (nivolumab) plus Yervoy (ipilimumab). Opdivo-based treatments are helping improve outcomes as first-line treatment for lung cancer patients
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: